The aim of the present study was to investigate the prognostic significance of EGFR and HER-2/neu, and their downstream targets AKT, ERK and PTEN in a large series of 232 epithelial ovarian cancer patients using the tissue microarray (TMA) platform. The gene discussed is PTEN; the disease is ovarian carcinoma.